ArticleHealth science reports2026
Assessing Functional Recovery in Ischemic Stroke: An Observational Study of Dual vs. Single Antiplatelet Therapy in Indian Patients.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: In an aging population, stroke is a leading cause of morbidity and mortality. More than 80% of stroke cases in the elderly are ischemic strokes. Stroke is the sixth most common cause of disability globally and the second most common cause after ischemic heart disease (IHD). This study aimed to assess the effects of aspirin alone (monotherapy) and clopidogrel and aspirin (combination treatment) on individuals with acute ischemic stroke. Methods: This is a Prospective, non-randomized, and observational study conducted in a tertiary care teaching hospital with 116 acute ischemic stroke patients from January 2023 to September 2024. Clopidogrel at an initial dose of 300 mg, followed by 75 mg per day for 90 days, plus aspirin at a dose of 75 mg per day for the first 21 days) or aspirin (75 mg per day for 90 days) group. Results: In our study, the majority of patients were more than 60 years, and the least were less than 40 years in both the groups. Predominant were male than female in both the groups. The mRS 3-6 occurred in three patients in the DAPT group and three patients in the monotherapy group, showing no statistically significant difference. Poor quality of life at 90 days occurred in one patient in the clopidogrel aspirin group and in two in the aspirin group ( Conclusion: In this observational study, the patients with acute Ischemic Stroke, given treatment with clopidogrel and aspirin, provided significantly better functional outcomes and disability scores in the next 90 days than aspirin alone. However, these findings should be interpreted within the context of an observational design and limited follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.